EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The prevention of alloxan induced diabetes in mice by the iron chelator di ethylenetriamine penta acetic acid suggestion of a role for iron in the cyto toxic process


Experientia (Basel) 38(3): 378-379
The prevention of alloxan induced diabetes in mice by the iron chelator di ethylenetriamine penta acetic acid suggestion of a role for iron in the cyto toxic process
DETAPAC, an Fe-chelating agent, given to male Swiss-Webster mice prior to alloxan, was able to protect the mice from the diabetogenic actions of alloxan. EDTA, another chelating agent, offered no protection. Possible mechanisms for these effects, including inhibiting of OH radical formation were discussed.


Accession: 006740588



Related references

The prevention of alloxan-induced diabetes in mice by the iron-chelator detapac: suggestion of a role for iron in the cytotoxic process. Experientia 38(3): 378-379, 1982

Removal of plutonium from beagles using calcium di ethylenetriamine penta acetic acid and zinc di ethylenetriamine penta acetic acid effects of initial di ethylenetriamine penta acetic acid injection. Health Physics 35(2): 201-210, 1978

A study of the chelating agent di ethylenetriamine penta acetic acid using selective radio iron probes of res and parenchymal iron stores. Journal Of Laboratory & Clinical Medicine: 913-921, 1975

Renal clearance and brain tumor localization in mice of technetium 99m compounds of tin di ethylenetriamine pent acetic acid iron ascorbic acid di ethylenetriamine pent acetic acid and iron ascorbic acid. Journal of Nuclear Medicine 13(11): 834-842, 1972

Inhibition of iron stimulated catecholamine degradation by the iron chelators detapac di ethylenetriamine penta acetic acid and desferal potentially useful laboratory agents. Biochemical Pharmacology 30(21): 2945-2948, 1981

Effect of 2 iron chelators deferrioxamine and di ethylenetriamine penta acetic acid on the development of tolerance to the physical dependence on ethanol in mice. Drug & Alcohol Dependence 12(4): 371-379, 1983

Action of di ethylenetriamine penta acetic acid on hepatic plutonium part 2 di ethylenetriamine penta acetic acid induced removal of monomeric plutonium from mouse liver parenchymal cells. Radiation Research 76(1): 180-186, 1978

Action of di ethylenetriamine penta acetic acid on hepatic plutonium part 1 quantitation of the di ethylenetriamine penta acetic acid induced biliary excretion of plutonium in the rat. Radiation Research 74(1): 179-185, 1978

The fenton reaction between iron ii di ethylenetriamine penta acetic acid and hydrogen per oxide. S Letters: 258-260, 1982

Metabolism and toxicity of therapeutic chelating agents part 15 effects of calcium di ethylenetriamine penta acetic acid and zinc di ethylenetriamine penta acetic acid on blood coagulation. Strahlentherapie 153(10): 704-710, 1977